Recommendations for economic evaluations of cell and gene therapies: a systematic literature review with critical appraisal

Mondher Toumia Laboratoire de Santé Publique, Aix-Marseille Université, Public Health Department, Marseille, FranceCorrespondence[email protected]

https://orcid.org/0000-0001-7939-7204 View further author information

Omar Dabbousb Global Geneconomics and Outcomes Research, Novartis Gene Therapies, Inc, Bannockburn, IL, USAView further author information

Samuel Aballéac Creativ-Ceutical, Paris, FranceView further author information

Michael F. Drummondd Centre for Health Economics, University of York, York, UK

https://orcid.org/0000-0002-6968-4610 View further author information

Johann-Matthias Graf von der Schulenburge Institute for Risk and Insurance, Leibniz Universtät Hannover, Hanover, GermanyView further author information

Daniel C. Malonef Department of Pharmacotherapy, University of Utah, Salt Lake City, UT, USAView further author information

Peter J. Neumanng Center for the Evaluation of Value and Risk in Health at the Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USAView further author information

Sean D. Sullivanh CHOICE Institute, University of Washington, Seattle, WA, USAView further author information

Sean Tunisi Rubix Health, Baltimore, MD, USAView further author information

show all

Recommendations for economic evaluations of cell and gene therapies: a systematic literature review with critical appraisal

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Recommendations for economic evaluations of cell and gene therapies: a systematic literature review with critical appraisal

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date